Clark Love & Hutson
Bg Banner
Clark Love & Hutson

The Nationally Recognized Plaintiffs Litigation
Law Firm

The Nationally Recognized Plaintiffs Litigation Law Firm

Was the facility where my medication was manufactured sterile?

On Behalf of | Jun 30, 2022 | Dangerous Drug Litigation |

When Texans and people throughout the nation use medications and medical products, they may have minor concerns that it could be dangerous and recalls might be initiated. Since taking medications and using items that are supposed to be safe is placing trust in companies, manufacturers and regulatory agencies, it can be a shock if dangers are discovered.

Often, this is related to mistakes, unexpected side effects and other problems that came about after it went to market and wound up in consumers’ hands. Another factor is if the facility where it was made was sufficiently sterile. After a recall, people who might have been harmed should assess their options.

Drug recall initiated due to potential lack of sterility

Because of Food and Drug Administration (FDA) concerns regarding sterility, a pharmaceutical company in South Carolina recalled 2.1 million doses of medicine. The company, Nephron, makes generic drugs and products. The company asserts that there were no reported problems with people using their products and that the recall was done voluntarily in the interest of safety.

This is not the first recall that has impacted Nephron. In 2015, it recalled an asthma medication due to it being discolored. The FDA had a dispute with the company prior to that because of its marketing of an asthma treatment product that was sold over the counter. According to its marketing, the company makes products for respiratory treatment and more.

Drug companies should be held responsible for errors and damage

After injuries, illness or a worsened condition by a drug that was subsequently recalled for any reason, those who have been affected might not know what they can do. Since medical expenses, long-term damage and even death can result from defective drugs, people should hold the company accountable.

This could stem from negligence, an absence of information, mistakes in manufacturing the drugs and the facility not being up to standard for safety. Gathering evidence, analyzing the circumstances and deciding on a path forward will generally require experienced help. For advice in how to pursue a claim, it is important to have guidance from the start.